Attention has focused on oseltamivir (Tamiflu; Roche, Nutley, NJ, USA) due to the era of the influenza A (H1N1) pandemic. Oseltamivir is an ester prodrug of oseltamivir carboxylate, a selective inhibitor of influenza viruses A and B neuraminidase. [1] The most frequent adverse events are nausea and vomiting, but neuropsychiatric events and skin and hypersensitivity reactions are often also observed. [1] However, acute angle-closure glaucoma (AACG) and transient myopia attributed to oseltamivir have not been reported previously. Here, we report on a patient with oseltamivir-induced AACG and transient myopia with an ultrasound biomicroscopic description of the pathogenic mechanism.
Case Report
A 27 year old woman experienced acute-onset blurry vision and ocular pain in both eyes four days after beginning oseltamivir therapy (75 mg twice daily) for suspected influenza. Her medical and ocular history was unremarkable and she had never worn glasses. Before arriving at our hospital, her intraocular pressure (IOP) measured 60 mmHg OU. A diagnosis of bilateral AACG was made by her local ophthalmologist because of increased IOP and severely shallow anterior chambers with cornea edema. She was treated with oral acetazolamide, topical timolol/dorzolamide combination, At that time, real-time reverse transcription polymerase chain reaction (RT-PCR) using an AB H1N1 PCR Kit (Applied Biosystems, CA, USA) for the specimen obtained from the nasopharyngeal swab was negative for influenza A virus antigen. The swine origin influenza A/H1N1 was not detected in influenza A virus PCR. The diagnosis of probable oseltamivir-induced AACG was suspected because there was no other detectable origin of the AACG, and the clinical features of our patient appeared similar to those of other drug-induced cases of AACG. Oseltamivir was the only medication being used by the patient when she developed acute-onset blurry vision. Oseltamivir was discontinued, and she was treated with topical prednisolone acetate and cycloplegic agents. Three days annular ciliochoroidal effusion had resolved in both eyes. Anti-glaucoma medications, a corticosteroid, and cycloplegic eye drops were subsequently discontinued. 
Discussion
Bilateral AACG and transient myopia may be induced by drugs, such as topiramate, [2] 3,4-methylenedioxymethamphetamine, [3] and cabergoline. [4] On the basis of the previous reports, different possible mechanisms of drug-induced AACG have been proposed, including ciliary body swelling [2, 3] and ciliochoroidal effusion. [2] [3] [4] In the presented patient, UBM findings of ciliochoroidal effusion during the acute stage with resolution of these findings during the convalescent stage indicated that the mechanism of bilateral AACG and transient myopia was related to the ciliochoroidal effusion. Ciliochoroidal effusion causes an anterior rotation of the ciliary body, which results in the anterior displacement of the lens-iris diaphragm. The annular ciliochoroidal effusion reduces the distance between the opposing ciliary processes and slackens the lens zonules, which results in an increase in the lens thickness. These changes may lead to AACG associated with shallow anterior chambers and myopia, as seen in our patient.
Ciliochoroidal effusion has been reported in association with dopaminergic drugs. [3, 4] The systemic administration of oseltamivir increased dopamine release in the rat medial prefrontal cortex in the previous study. [5] The authors postulated that the increase in the dopamine during oseltamivir treatment may have caused an abnormal behavior in young patients. [5] Dopaminergic neuron in the eye and the presence of aqueous humor dopamine and adenylate cyclase linked dopamine receptors in the ciliary body have been reported in the experimental study. [6] [7] [8] Therefore, fluid movement in ciliochoroidal effusion in the presented patient may be related to the membrane potential alteration induced by the effects of dopamine on adenylate cyclase. [3, 9] 
Conclusion
To our knowledge, this is the first reported case of ciliochoroidal effusion associated with oseltamivir. The results obtained from this patient suggest that a history of oseltamivir must be determined in a patient with bilateral AACG and transient myopia due to ciliochoroidal effusion.
